Evaluating the Effectiveness of Repricing for Market Expansion in the Japanese Drug Pricing System

Conclusions: On the basis of these results, we propose that the current repricing system be replaced with one using a market mechanism that can evaluate the value of drugs from an economic perspective and help improving the financial performance of the national health insurance system. We also suggest that the number of generic medications on the market in Japan be increased to a ratio equivalent to those of the US and EU. We hope that the perspectives on Japan’s unique drug pricing system obtained from this article are utilized by pharmaceutical companies in developing their businesses in Japan.
Source: Therapeutic Innovation and Regulatory Science - Category: Drugs & Pharmacology Authors: Tags: Global Perspectives Source Type: research